Cargando…

MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5

The blood-tumor barrier (BTB) hinders delivery of chemotherapeutic drugs to tumors in the brain; previous studies have shown that the BTB can be selectively opened by endothelial monocyte activating polypeptide-II (EMAP-II), but the specific mechanism involved remains elusive. In this study, we foun...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liangyu, Xue, Yixue, Zheng, Jian, Liu, Xiaobai, Liu, Jing, Chen, Jiajia, Li, Zhen, Xi, Zhuo, Teng, Hao, Wang, Ping, Liu, Libo, Liu, Yunhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808301/
https://www.ncbi.nlm.nih.gov/pubmed/29467620
http://dx.doi.org/10.3389/fnmol.2018.00035
_version_ 1783299445253734400
author Chen, Liangyu
Xue, Yixue
Zheng, Jian
Liu, Xiaobai
Liu, Jing
Chen, Jiajia
Li, Zhen
Xi, Zhuo
Teng, Hao
Wang, Ping
Liu, Libo
Liu, Yunhui
author_facet Chen, Liangyu
Xue, Yixue
Zheng, Jian
Liu, Xiaobai
Liu, Jing
Chen, Jiajia
Li, Zhen
Xi, Zhuo
Teng, Hao
Wang, Ping
Liu, Libo
Liu, Yunhui
author_sort Chen, Liangyu
collection PubMed
description The blood-tumor barrier (BTB) hinders delivery of chemotherapeutic drugs to tumors in the brain; previous studies have shown that the BTB can be selectively opened by endothelial monocyte activating polypeptide-II (EMAP-II), but the specific mechanism involved remains elusive. In this study, we found that microRNA-429 (miR-429) expression in glioma vascular endothelial cells (GECs) was far lower than in human brain microvascular endothelial cells (ECs). miR-429 had lower expression in GECs and glioma tissues compared to ECs or normal tissues of the brain. Furthermore, miR-429 had lower expression in high grade glioma (HGG) than in low grade glioma (LGG). In in vitro BTB models, we also found that EMAP-II significantly increased BTB permeability, decreased expression of ZO-1, occludin and claudin-5 in GECs, in a time- and dose-dependent manner. EMAP-II greatly increased miR-429 expression in GECs of the BTB models in vitro. Overexpression of miR-429 in GECs significantly decreased the transepithelial electric resistance (TEER) values in BTB models, and led to enhanced horseradish peroxidase (HRP) flux. Overexpression of miR-429 in GECs significantly decreased the expression of tight junction (TJ)-associated proteins (ZO-1, occludin and claudin-5), and decreased the distribution continuity. Silencing of miR-429 in GECs increased the expression of TJ-associated proteins and the distribution continuity. The dual-luciferase reporter assay revealed that ZO-1 and occludin were target genes of miR-429, and we demonstrated that miR-429 overexpression markedly down-regulated protein expression of p70S6K, as well as its phosphorylation levels. The dual-luciferase reporter assay also showed that p70S6K was a target gene of miR-429; miR-429 overexpression down-regulated expression and phosphorylation levels of p70S6K, and also decreased phosphorylation levels of S6 and increased BTB permeability. Conversely, silencing of miR-429 increased the expression and phosphorylation levels of p70S6K, and increased phosphorylation levels of S6, while decreasing BTB permeability. In conclusion, the results indicated that EMAP-II caused an increase in miR-429 expression that directly targeted TJ-associated proteins, which were negatively regulated; on the other hand, miR-429 down-regulated the expression of TJ-associated proteins by targeting p70S6K, also negatively regulated. As a result, the BTB permeability increased.
format Online
Article
Text
id pubmed-5808301
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58083012018-02-21 MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5 Chen, Liangyu Xue, Yixue Zheng, Jian Liu, Xiaobai Liu, Jing Chen, Jiajia Li, Zhen Xi, Zhuo Teng, Hao Wang, Ping Liu, Libo Liu, Yunhui Front Mol Neurosci Neuroscience The blood-tumor barrier (BTB) hinders delivery of chemotherapeutic drugs to tumors in the brain; previous studies have shown that the BTB can be selectively opened by endothelial monocyte activating polypeptide-II (EMAP-II), but the specific mechanism involved remains elusive. In this study, we found that microRNA-429 (miR-429) expression in glioma vascular endothelial cells (GECs) was far lower than in human brain microvascular endothelial cells (ECs). miR-429 had lower expression in GECs and glioma tissues compared to ECs or normal tissues of the brain. Furthermore, miR-429 had lower expression in high grade glioma (HGG) than in low grade glioma (LGG). In in vitro BTB models, we also found that EMAP-II significantly increased BTB permeability, decreased expression of ZO-1, occludin and claudin-5 in GECs, in a time- and dose-dependent manner. EMAP-II greatly increased miR-429 expression in GECs of the BTB models in vitro. Overexpression of miR-429 in GECs significantly decreased the transepithelial electric resistance (TEER) values in BTB models, and led to enhanced horseradish peroxidase (HRP) flux. Overexpression of miR-429 in GECs significantly decreased the expression of tight junction (TJ)-associated proteins (ZO-1, occludin and claudin-5), and decreased the distribution continuity. Silencing of miR-429 in GECs increased the expression of TJ-associated proteins and the distribution continuity. The dual-luciferase reporter assay revealed that ZO-1 and occludin were target genes of miR-429, and we demonstrated that miR-429 overexpression markedly down-regulated protein expression of p70S6K, as well as its phosphorylation levels. The dual-luciferase reporter assay also showed that p70S6K was a target gene of miR-429; miR-429 overexpression down-regulated expression and phosphorylation levels of p70S6K, and also decreased phosphorylation levels of S6 and increased BTB permeability. Conversely, silencing of miR-429 increased the expression and phosphorylation levels of p70S6K, and increased phosphorylation levels of S6, while decreasing BTB permeability. In conclusion, the results indicated that EMAP-II caused an increase in miR-429 expression that directly targeted TJ-associated proteins, which were negatively regulated; on the other hand, miR-429 down-regulated the expression of TJ-associated proteins by targeting p70S6K, also negatively regulated. As a result, the BTB permeability increased. Frontiers Media S.A. 2018-02-07 /pmc/articles/PMC5808301/ /pubmed/29467620 http://dx.doi.org/10.3389/fnmol.2018.00035 Text en Copyright © 2018 Chen, Xue, Zheng, Liu, Liu, Chen, Li, Xi, Teng, Wang, Liu and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Chen, Liangyu
Xue, Yixue
Zheng, Jian
Liu, Xiaobai
Liu, Jing
Chen, Jiajia
Li, Zhen
Xi, Zhuo
Teng, Hao
Wang, Ping
Liu, Libo
Liu, Yunhui
MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5
title MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5
title_full MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5
title_fullStr MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5
title_full_unstemmed MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5
title_short MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5
title_sort mir-429 regulated by endothelial monocyte activating polypeptide-ii (emap-ii) influences blood-tumor barrier permeability by inhibiting the expressions of zo-1, occludin and claudin-5
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808301/
https://www.ncbi.nlm.nih.gov/pubmed/29467620
http://dx.doi.org/10.3389/fnmol.2018.00035
work_keys_str_mv AT chenliangyu mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT xueyixue mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT zhengjian mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT liuxiaobai mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT liujing mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT chenjiajia mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT lizhen mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT xizhuo mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT tenghao mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT wangping mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT liulibo mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5
AT liuyunhui mir429regulatedbyendothelialmonocyteactivatingpolypeptideiiemapiiinfluencesbloodtumorbarrierpermeabilitybyinhibitingtheexpressionsofzo1occludinandclaudin5